Orotate (orotic acid): An essential and versatile molecule.

Abstract

Orotate (OA) is well-known as a precursor in biosynthesis of pyrimidines; in mammals it is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. OA is also a normal part of the diet, being found in milk and dairy products, and it is converted to uridine for use in the pyrimidine salvage pathway predominantly in liver, kidney and erythrocytes. Early research into nutrition identified orotate as "vitamin B13," and its use as a complex with organic cations or metal ions was promulgated in body-building, and in assisting therapies of metabolic syndromes. It has recently been established that the amelioration of gout by dairy products arises from the competition of orotate and urate at the hURAT1 transporter. The orotic aciduria that arises in children with defective UMP synthase can be rescued by oral uridine therapy, since UMP is the end-product and also a feedback inhibitor of the de novo pathway. In contrast, Miller (dysmorphology) syndrome is connected with defects in DHODH, and hence in the supply of OA, and cannot be helped by uridine. Other models of dysmorphisms are connected with enzymes early in the pyrimidine de novo pathway. We conclude that the OA molecule is itself required for the regulation of genes that are important in the development of cells, tissues and organisms.

• Authors: M Löffler, E A Carrey, E Zameitat
• Journal: Nucleosides, nucleotides & nucleic acids (Nucleosides Nucleotides Nucleic Acids) Vol. 35 Issue 10-12 Pg. 566-577 (Dec 2016) ISSN: 1532-2335 [Electronic] United States
• PMID: 27906623 (Publication Type: Journal Article, Review)

Chemical References

• Anticholesteremic Agents
• Orotic Acid

Topics

• Animals
• Anticholesteremic Agents (pharmacology, therapeutic use)
• Diet
• Humans
• Orotic Acid (metabolism, pharmacology, therapeutic use)